The morphomolecular features of cholangiocarcinoma in the personalised era.Field D, Carpino G, Doukas M, Kendall TJ.
|
Recommendations maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.Kendall T, Overi D, Guido M, Braconi C, Banales J, Cardinale V, Gaudio E, Koerkamp BG, Carpino G.
|
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.Ortiz-Rivero S, Peleteiro-Vigil A, Abete L, Lozano E, Hammer HS, Giacomo SD, Abad M, Boix L, Forner A, Reig M, Macias RIR, Pötz O, Marin JJG, Briz O.
|